Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Unknown 3Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Vomiting 2Neoplasms 2

Interventions

Exercise 57Radiotherapy 49Blood Specimen Collection 45Radiosurgery 35Drug Therapy 33Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19Control Groups 19camrelizumab 16Propofol 16Metformin 16Cytarabine 16Surveys and Questionnaires 15Preoperative Exercise 15Injections 15Fluorouracil 15anlotinib 14Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Unknown × fosaprepitant × Clear all
NCT05755659 2023-03-06

COSEFDIP

Xijing Hospital

Phase NA Unknown
3,000 enrolled
Tumor-Agnostic

Neoplasms

NCT05230654 2022-02-09

Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs

Shanghai Children's Medical Center

Phase NA Unknown
120 enrolled

Vomiting

NCT04873284 2021-05-10

Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients

Shanghai Children's Medical Center

Phase NA Unknown
120 enrolled

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡